Metformin-Associated Lactic Acidosis and Acute Kidney Injury
Abstract
Keywords
Supporting Institution
References
- Perveen W, Ahsan H, Shahzad R, Fayyaz S, Zaif A, Paracha MA, Alghadir AH. Prevalence of peripheral neuropathy, amputation, and quality of life in patients with diabetes mellitus. Scientific Reports, 2024;14(1):14430. https://doi.org/10.1038/s41598-024-65495-2
- Song A, Zhang C, Meng X. Mechanism and application of metformin in kidney diseases: An update. Biomedicine & Pharmacotherapy, 2021;138:111454. https://doi.org/10.1016/j.biopha.2021.111454.
- Aldobeaban S, Mzahim B and Alshehri AA. Recurrent hypoglycemia secondary to metformin toxicity in the absence of co-ingestions: a case repor, JMCR 2018; 12:223. https://doi.org/10.1186/s13256-018-1758-0
- CorcoranC. Metformin. ; Tibb F. Jacobs. StatPearls Publishing; 2024
- Dyatlova N, Tobarran NV, Kannan L, North R, Wills BK. Metformin associated lactic acidosis (MALA). 2022.
- Simon EL, Sherry AC, Rabinowitz J. Metformin-Associated Lactic Acidosis-Is This on Your Radar?. JEM, 2024;66(4): e530-e533. https://doi.org/10.1016/j.jemermed.2023.11.017
- DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabol, 2016;65(2): 20-29. https://doi.org/10.1016/j.metabol.2015.10.014.
- Di Mauro S, Filippello A, Scamporrino A, Purrello F, Piro S, Malaguarnera R. Metformin: when should we fear lactic acidosis?. Int. J. Mol. Sci, 2022;23(15):8320. https://doi.org/10.3390/jms23158320
Details
Primary Language
English
Subjects
Internal Diseases
Journal Section
Case Report
Authors
Can Hüzmeli
*
0000-0002-5499-4886
Türkiye
Publication Date
April 12, 2025
Submission Date
October 17, 2024
Acceptance Date
December 30, 2024
Published in Issue
Year 2025 Volume: 16 Number: 54